老年2型糖尿病患者糖尿病护理的挑战及基础胰岛素的作用
Challenges of Diabetes Care in Older People With Type 2 Diabetes and the Role of Basal Insulin.
作者信息
Cersosimo Eugenio, Lee Pearl G, Pandya Naushira
机构信息
Texas Diabetes Institute, University Health System and the University of Texas Health Science Center at San Antonio, San Antonio, TX.
Division of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
出版信息
Clin Diabetes. 2019 Oct;37(4):357-367. doi: 10.2337/cd18-0074.
Abstract
The use of long-acting basal insulin analogs is a recommended strategy in older people with diabetes because of their lower risk of hypoglycemia compared to intermediate-acting insulins. In this article, we review the results from recent clinical trials of second-generation basal insulin preparations. We conclude that, although these preparations have improved the management of insulin-requiring older people with type 2 diabetes, there is a need for additional and more specific studies to address the complexities of hyperglycemia management in this population.
摘要
由于与中效胰岛素相比，长效基础胰岛素类似物导致低血糖的风险较低，因此在老年糖尿病患者中使用长效基础胰岛素类似物是一种推荐的策略。在本文中，我们回顾了第二代基础胰岛素制剂近期临床试验的结果。我们得出结论，尽管这些制剂改善了需要胰岛素治疗的老年2型糖尿病患者的管理，但仍需要进行更多专门研究，以解决该人群高血糖管理的复杂性问题。
相似文献
1
Challenges of Diabetes Care in Older People With Type 2 Diabetes and the Role of Basal Insulin.老年2型糖尿病患者糖尿病护理的挑战及基础胰岛素的作用
Clin Diabetes. 2019 Oct;37(4):357-367. doi: 10.2337/cd18-0074.
2
The role of the new basal insulin analogs in addressing unmet clinical needs in people with type 1 and type 2 diabetes.新型基础胰岛素类似物在满足1型和2型糖尿病患者未被满足的临床需求方面的作用。
Curr Med Res Opin. 2017 Jun;33(6):1045-1055. doi: 10.1080/03007995.2017.1298522. Epub 2017 Mar 24.
3
Addressing hyperglycemia from hospital admission to discharge.处理从住院到出院期间的高血糖问题。
Curr Med Res Opin. 2010 Mar;26(3):589-98. doi: 10.1185/03007990903566822.
4
Current usage of long-acting insulin analogs in patients with type 2 diabetes mellitus.目前 2 型糖尿病患者长效胰岛素类似物的使用情况。
Expert Rev Endocrinol Metab. 2024 Mar;19(2):155-161. doi: 10.1080/17446651.2024.2320631. Epub 2024 Feb 20.
5
Efficacy and safety of the second generation basal insulin analogs in type 2 diabetes mellitus: A critical appraisal.第二代基础胰岛素类似物在2型糖尿病中的疗效与安全性：一项批判性评估。
Diabetes Metab Syndr. 2019 May-Jun;13(3):2126-2141. doi: 10.1016/j.dsx.2019.05.001. Epub 2019 May 12.
6
Clinical perspectives on the frequency of hypoglycemia in treat-to-target randomized controlled trials comparing basal insulin analogs in type 2 diabetes: a narrative review.关于 2 型糖尿病中基础胰岛素类似物治疗目标比较的随机对照试验中低血糖发生频率的临床观点：叙述性综述。
BMJ Open Diabetes Res Care. 2024 May 14;12(3):e003930. doi: 10.1136/bmjdrc-2023-003930.
7
Biosynthetic Human Insulin and Insulin Analogs.生物合成人胰岛素和胰岛素类似物。
Am J Ther. 2020 Jan/Feb;27(1):e42-e51. doi: 10.1097/MJT.0000000000001089.
8
Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practice.了解基础胰岛素类似物的药代动力学和药效学差异如何影响临床实践。
Curr Med Res Opin. 2017 Oct;33(10):1821-1831. doi: 10.1080/03007995.2017.1335192. Epub 2017 Jun 23.
9
Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.用于 1 型和 2 型成年糖尿病患者群体的持续皮下胰岛素输注（CSII）泵：一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(20):1-58. Epub 2009 Oct 1.
10
Considerations for Insulin-Treated Type 2 Diabetes Patients During Hospitalization: A Narrative Review of What We Need to Know in the Age of Second-Generation Basal Insulin Analogs.胰岛素治疗的2型糖尿病患者住院期间的注意事项：关于第二代基础胰岛素类似物时代我们需要了解的内容的叙述性综述
Diabetes Ther. 2020 Dec;11(12):2775-2790. doi: 10.1007/s13300-020-00920-z. Epub 2020 Sep 30.
引用本文的文献
1
Hypoglycaemia in Older Adults with Diabetes: Pathophysiology, Prevention, and Personalized Care in an Aging Population.老年糖尿病患者的低血糖症：老年人群中的病理生理学、预防及个性化护理
Drugs Aging. 2025 Sep 10. doi: 10.1007/s40266-025-01236-y.
2
Healthcare utilization and costs in adults with type 2 diabetes treated with first or second-generation basal insulins in England.在英国，使用第一代或第二代基础胰岛素治疗的2型糖尿病成人患者的医疗保健利用情况及费用
BMJ Open Diabetes Res Care. 2025 May 28;13(3):e005027. doi: 10.1136/bmjdrc-2025-005027.
3
A qualitative study of the experiences of insulin use by older people with type 2 diabetes mellitus.一项关于老年 2 型糖尿病患者使用胰岛素的体验的定性研究。
BMC Prim Care. 2024 May 22;25(1):180. doi: 10.1186/s12875-024-02318-3.
4
DIVE/DPV registries: benefits and risks of analog insulin use in individuals 75 years and older with type 2 diabetes mellitus.DIVE/DPV 登记研究：2 型糖尿病患者年龄≥75 岁人群中使用人胰岛素类似物的获益与风险。
BMJ Open Diabetes Res Care. 2021 Jun;9(1). doi: 10.1136/bmjdrc-2021-002215.
5
Challenges and Strategies for Managing Diabetes in the Elderly in Long-Term Care Settings.长期护理机构中老年人糖尿病管理的挑战与策略
Diabetes Spectr. 2020 Aug;33(3):236-245. doi: 10.2337/ds20-0018.
本文引用的文献
1
A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study.一项比较甘精胰岛素 300 单位/毫升与 100 单位/毫升在老年 2 型糖尿病患者中的疗效和安全性的随机对照试验：来自 SENIOR 研究的结果。
Diabetes Care. 2018 Aug;41(8):1672-1680. doi: 10.2337/dc18-0168. Epub 2018 Jun 12.
2
1. Improving Care and Promoting Health in Populations: .改善人群健康护理和促进健康：
Diabetes Care. 2018 Jan;41(Suppl 1):S7-S12. doi: 10.2337/dc18-S001.
3
International Consensus on Use of Continuous Glucose Monitoring.连续血糖监测应用的国际共识
Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600.
4
INSULIN GLARGINE 300 U/ML IS ASSOCIATED WITH LESS WEIGHT GAIN WHILE MAINTAINING GLYCEMIC CONTROL AND LOW RISK OF HYPOGLYCEMIA COMPARED WITH INSULIN GLARGINE 100 U/ML IN AN AGING POPULATION WITH TYPE 2 DIABETES.在 2 型糖尿病老年人群中，与胰岛素甘精 100U/ml 相比，胰岛素甘精 300U/ml 可在维持血糖控制的同时降低体重增加风险，低血糖风险较低。
Endocr Pract. 2018 Feb;24(2):143-149. doi: 10.4158/EP171922.OR. Epub 2017 Nov 6.
5
Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus.甘精胰岛素300 U/mL用于1型和2型糖尿病的基础胰岛素治疗。
Diabetes Metab Syndr Obes. 2017 Jun 30;10:273-284. doi: 10.2147/DMSO.S131358. eCollection 2017.
6
Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes.年龄、性别和体重指数对基础胰岛素类似物 100U/mL 联合口服降糖药治疗 2 型糖尿病的疗效和低血糖结局的影响：一项基于目标的临床试验分析。
Diabetes Obes Metab. 2017 Nov;19(11):1546-1554. doi: 10.1111/dom.12966. Epub 2017 Jul 27.
7
Insulin analogues in type 1 diabetes mellitus: getting better all the time.1 型糖尿病中的胰岛素类似物：一直不断改善。
Nat Rev Endocrinol. 2017 Jul;13(7):385-399. doi: 10.1038/nrendo.2017.39. Epub 2017 Apr 21.
8
Liberating A1C goals in older adults may not protect against the risk of hypoglycemia.在老年人中放宽糖化血红蛋白（A1C）目标可能无法预防低血糖风险。
J Diabetes Complications. 2017 Jul;31(7):1197-1199. doi: 10.1016/j.jdiacomp.2017.02.014. Epub 2017 Mar 14.
9
The Pathophysiology of Hyperglycemia in Older Adults: Clinical Considerations.老年人高血糖的病理生理学：临床注意事项。
Diabetes Care. 2017 Apr;40(4):444-452. doi: 10.2337/dc16-1732.
10
Efficacy and safety of thrice-weekly insulin degludec in elderly patients with type 2 diabetes assessed by continuous glucose monitoring.通过持续葡萄糖监测评估老年2型糖尿病患者每周三次德谷胰岛素的疗效和安全性。
Endocr J. 2016 Dec 30;63(12):1099-1106. doi: 10.1507/endocrj.EJ16-0252. Epub 2016 Sep 2.
Zotero 插件